科源制药(301281.SZ)：目前公司暂未布局保健品原料药

Group 1 - The company focuses on the chronic disease sector, specifically in the areas of three highs (hypertension, hyperglycemia, and hyperlipidemia) and cardiovascular raw materials [1] - The main raw materials for diabetes treatment include Glimepiride and Metformin Hydrochloride, while the primary cardiovascular raw material is Isosorbide Mononitrate [1] - Currently, the company has not ventured into the health supplement raw materials market [1]